Showing results (431-440 of 461) with videos related to

Sort By:
Pageof 47
Therapeutic Drug Monitoring|April 22, 2024
Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical LaboratoryPaula Elizabeth Keating, Barry D Hock, Paul K L Chin, et al.
Diseases of the Colon and Rectum|November 1, 1993
ColpocystodefecographyD Hock, R Lombard, C Jehaes, et al.
Journal of Immunological Methods|September 17, 2019
Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serumBarry D Hock, Stewart M Smith, Christopher J McEntyre, et al.
Leukemia Research|February 7, 2009
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemiaB D Hock, L J Fernyhough, S M Gough, et al.
Leukemia Research|December 23, 2003
The soluble form of CD83 is present at elevated levels in a number of hematological malignanciesBarry D Hock, Lisa F Haring, Alexander Steinkasserer, et al.
Internal Medicine Journal|November 10, 2018
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centreBarry D Hock, Katie S Mulholland, Peter Ganly, et al.
Internal Medicine Journal|September 25, 2016
Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patientsB D Hock, N D McIntosh, J L McKenzie, et al.
Pageof 47